Journal of Lung Cancer Diagnosis & Treatment
Open Access

Professor Ferlito has collaborated in writing articles, editorials, commentaries, consensus statements, letters to the editor, special issues, book chapters and books with 600 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), Surgical Pathology of Laryngeal Neoplasms (Chapman and Hall, London, 1996) and Diseases of the Larynx (Arnold, London, 2000), and co-authored two books entitled Granulomas and Neoplasms of the Larynx together with Professor Imrich Friedmann (Churchill Livingstone, Edinburgh, 1988) and Surgery for Cancer of the Larynx and Related Structures together with Dr. Carl E. Silver (Saunders, Philadelphia, 1996). He is editor with Dr. Marvin P. Fried of the third edition of a two-volume book entitled The Larynx (Plural Publishing, San Diego, 2009) and with Drs. K. Thomas Robbins and Carl E. Silver of the book entitled Neck Dissection - Management of Regional Disease in Head and Neck Cancer (Plural Publishing, San Diego, 2010). He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. Professor Ferlito has been author or co-author of 593 referred publications in 55 medical journals and 54 chapters in various books.

Professor Ferlito has been awarded ad hominem fellowship from the Royal College of Surgeons of Edinburgh and ad eundem fellowship from the Royal College of Surgeons of England, Glasgow, Ireland and Dental Surgery of the Royal College of Surgeons of England. He is a fellow or a member of the American College of Surgeons, the Royal College of Pathologists, the Royal Society of Medicine of London, the American Otological Society, the American Laryngological Association, the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum, the American Laryngological Rhinological and Otological Association, the American Society for Head and Neck Surgery, the Society of Head and Neck Surgeons, the American Broncho-Esophagological Association, the American Rhinologic Society, the Association for Research in Otolaryngology, the American Academy of Otolaryngology-Head and Neck Surgery, the International Broncho-Esophagological Society, the Oto-Rhino-Laryngological Society of Japan, the Japan Laryngological Association, the American Association for the Advancement of Science, the Hungarian Association of Otorhinolaryngologists (Honorary), the Slovenian Association of Otorhinolaryngologists, the Slovak Society of Otolaryngology-Head and Neck Surgery (Honorary), the Spanish Society of Otorhinolaryngology-Head and Neck Surgery (Honorary), the Israeli Society of Head and Neck Surgery and Oncology, the Hong Kong College of Otolaryngologists, the New York Academy of Sciences, the Laryngeal Cancer Association, Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie, the American Society for Clinical Pathology, the College of American Pathologists, the International Academy of Pathology, the International Academy of Oral Oncology and the Interventional Oncology Society.

Dr Georgia Hardavella is a Consultant Respiratory Physician and Lead for Lung Cancer and Bronchoscopy services at King’s College Hospital in London having received dedicated training for these at University College London (UCL). She has also recently set up and leads a dedicated Pulmonary Nodules Service at King's. She has developed clinical research projects at UCL (EBUS, photodynamic therapy) and is currently expanding the clinical research portfolio at King’s College London (pulmonary nodules/lung cancer). Her main research interests include prognostic markers in lung cancer and pulmonary nodules, interventional bronchoscopies and quality indexes in thoracic oncology. Dr Hardavella has received numerous awards (14) in a national and international level and has an extended portfolio of scientific and research activities in an international level; she is a member of the European Respiratory Society (ERS) Long Range Planning Committee for Thoracic Oncology and the ERS Lung Cancer Working Group. She is also a member of the Professional Advisory Committee in the European Lung Foundation (ELF) and has participated in numerous ELF driven projects promoting patient and public involvement (PPI) in research and clinical services. Being a co-investigator of the groundbreaking PEARL trial (Photodynamic Therapy in the Treatment of Early Lung Cancer) (funded by CRUK) she has created and managed a PPI group at UCL for this trial with excellent feedback. She is the Junior Member Representative of the Thoracic Oncology Assembly in the ERS Junior Members Committee and she participates in ERS Taskforces in Thoracic Oncology that aim to improve the quality of care in Thoracic Oncology in a European level. Since 2014 she leads the ‘How to do Science’ section in the Breathe Journal which is the educational journal of the ERS.

Pulmonary nodules, lung cancer